1|0|Public
50|$|<b>Batanopride</b> (BMY-25,801) is an {{antiemetic}} drug of the benzamide class {{which acts}} as a selective 5-HT3 receptor antagonist. It was trialled to reduce nausea during cancer chemotherapy, but was never approved for medical use due to dose-limiting side effects including hypotension and long QT syndrome.|$|E

